A review of surgical techniques to correct upper eyelid retraction associated with thyroid eye disease.
We review the literature pertinent to surgical correction of upper eyelid retraction resulting from thyroid eye disease (TED). Although novel nonsurgical treatment of TED-upper eyelid retraction has been described, with botulinum A toxin and hyaluronic acid; graded full-thickness blepharotomy remains the mainstay of treatment for the condition. Graded full-thickness anterior blepharotomy provides predictable, reproducible results and is a simple surgical procedure to master. For patients who cannot undergo surgical intervention, botulinum toxin offers a novel nonsurgical answer to lid retraction, but may be complicated by overcorrection and introduces an additional variable that needs to be considered when following the patient.